Elevated Expression Level of MicroRNA-196a Is Predictive of Intestinal-Type Intraductal Papillary Mucinous Neoplasm of the Pancreas
Author(s) -
Teppei Aso,
Takao Ohtsuka,
Koji Tamura,
Noboru Ideno,
Hiroshi Kono,
Yosuke Nagayoshi,
Kenoki Ohuchida,
Junji Ueda,
Shunnichi Takahata,
Koji Shindo,
Shinichi Aishima,
Yoshinao Oda,
Kazuhiro Mizumoto,
Masao Tanaka
Publication year - 2014
Publication title -
pancreas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.061
H-Index - 104
eISSN - 1536-4828
pISSN - 0885-3177
DOI - 10.1097/mpa.0000000000000042
Subject(s) - intestinal metaplasia , pancreas , intraductal papillary mucinous neoplasm , medicine , pancreatic cancer , microrna , cdx2 , pathology , mucin 2 , gastroenterology , real time polymerase chain reaction , cancer , biology , gene expression , gene , homeobox , biochemistry
Aberrant expression of several microRNAs (miRs) has been reported in various neoplasms including intraductal papillary mucinous neoplasms (IPMNs) of the pancreas. MicroRNA-196a (miR-196a) is up-regulated in Barrett esophagus (characterized by intestinal metaplasia) and in colorectal cancer; this relationship between intestinal characteristics and miR-196a might also be applicable to intestinal-type IPMNs. The aim of this study was to evaluate whether intestinal-type IPMNs can be discriminated from non-intestinal-type IPMNs by the expression level of miR-196a in tissue and pancreatic juice samples.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom